New York State Common Retirement Fund
PRTK

New York State Common Retirement Fund’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

New York State Common Retirement Fund’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-489
Closed -$1K – 3524
2022
Q2 		$1K Sell
489
-32,024
-98% -$69.9K ﹤0.01% 3450
2022
Q1 		$97K Sell
32,513
-65,900
-67% -$248K ﹤0.01% 3026
2021
Q4 		$442K Sell
98,413
-14,758
-13% -$70K ﹤0.01% 2495
2021
Q3 		$550K Buy
113,171
+92
+0.1% +$507 ﹤0.01% 2413
2021
Q2 		$771K Sell
113,079
-21,295
-16% -$172K ﹤0.01% 2352
2021
Q1 		$949K Buy
134,374
+50,850
+61% +$366K ﹤0.01% 2151
2020
Q4 		$523K Buy
83,524
+9,350
+13% +$55K ﹤0.01% 2329
2020
Q3 		$401K Hold
74,174
– – ﹤0.01% 2324
2020
Q2 		$387K Hold
74,174
– – ﹤0.01% 2339
2020
Q1 		$234K Buy
74,174
+850
+1% +$3.14K ﹤0.01% 2389
2019
Q4 		$295K Buy
73,324
+38,350
+110% +$133K ﹤0.01% 2551
2019
Q3 		$151K Buy
34,974
+2,020
+6% +$8.08K ﹤0.01% 2901
2019
Q2 		$131K Sell
32,954
-770
-2% -$3.66K ﹤0.01% 3010
2019
Q1 		$181K Sell
33,724
-800
-2% -$5.17K ﹤0.01% 2764
2018
Q4 		$177K Sell
34,524
-14,250
-29% -$108K ﹤0.01% 2765
2018
Q3 		$473K Hold
48,774
– – ﹤0.01% 2439
2018
Q2 		$497K Buy
48,774
+1,270
+3% +$14.4K ﹤0.01% 2455
2018
Q1 		$618K Buy
47,504
+17,321
+57% +$258K ﹤0.01% 2263
2017
Q4 		$540K Hold
30,183
– – ﹤0.01% 2321
2017
Q3 		$758K Sell
30,183
-9,216
-23% -$215K ﹤0.01% 2158
2017
Q2 		$950K Buy
39,399
+6,491
+20% +$143K ﹤0.01% 2071
2017
Q1 		$633K Buy
32,908
+2,586
+9% +$40.7K ﹤0.01% 2273
2016
Q4 		$467K Buy
30,322
+174
+0.6% +$2.26K ﹤0.01% 2401
2016
Q3 		$392K Buy
30,148
+6,863
+29% +$91K ﹤0.01% 2438
2016
Q2 		$324K Buy
23,285
+11,585
+99% +$171K ﹤0.01% 2484
2016
Q1 		$177K Hold
11,700
– – ﹤0.01% 2732
2015
Q4 		$222K Hold
11,700
– – ﹤0.01% 2709
2015
Q3 		$222K Buy
11,700
+4,826
+70% +$120K ﹤0.01% 2734
2015
Q2 		$177K Buy
+6,874
New +$195K ﹤0.01% 2958

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

New York State Common Retirement Fund's PRTK Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2022, closing a stake of 489 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in PRTK in Q2 2015 and held it in 29 quarters. The position peaked at $950K in Q2 2017. 72 funds tracked by Wall St. Rank hold PRTK as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 489 Paratek Pharmaceuticals, Inc. shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 29 quarters.
  • New York State Common Retirement Fund's Paratek Pharmaceuticals, Inc. position peaked at $950K in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.